Kolexia
Martinez Gomez Carlos
Gynécologie
Centre Oscar-Lambret
Lille, France
66 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du col de l'utérus Tumeurs de l'ovaire Carcinomes Récidive tumorale locale Tumeurs du péritoine Tumeurs de l'endomètre Complications postopératoires Métastase lymphatique Tumeurs de l'utérus

Industries

GSK
3 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PAROLA: PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   20 mars 2024
SENTIRAD: Randomized Study Comparing Sentinel Node (SN) Policy to Current French Initial Staging Protocols in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence
Essai Clinique (Centre Oscar-Lambret)   01 décembre 2023
Complex abdominal wall reconstruction for an isolated parietal recurrence of ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   20 novembre 2023
Fimbriectomy: Radical Fimbriectomy for Young BRCA Mutation Carriers at Risk of Pelvic Serous Carcinoma
Essai Clinique (Centre Oscar-Lambret)   30 juin 2023
Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   05 juin 2023
Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?
Cancers   02 mars 2023
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
Current oncology (Toronto, Ont.)   14 janvier 2023
Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.
Frontiers in oncology   02 décembre 2022
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints.
Cancers   29 octobre 2022
Circulating Exhausted PD-1 CD39 Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade.
Cancers   28 juillet 2022